1. Home
  2. HLF vs EVO Comparison

HLF vs EVO Comparison

Compare HLF & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Herbalife Ltd.

HLF

Herbalife Ltd.

HOLD

Current Price

$12.98

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.88

Market Cap

994.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLF
EVO
Founded
1980
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
994.5M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
HLF
EVO
Price
$12.98
$2.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$18.00
$7.00
AVG Volume (30 Days)
1.6M
30.3K
Earning Date
05-06-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.57
N/A
Revenue
$5,037,500,000.00
N/A
Revenue This Year
$4.97
$1.37
Revenue Next Year
$3.80
$10.05
P/E Ratio
$22.79
N/A
Revenue Growth
0.89
N/A
52 Week Low
$7.56
$2.31
52 Week High
$20.40
$4.42

Technical Indicators

Market Signals
Indicator
HLF
EVO
Relative Strength Index (RSI) 56.67 55.62
Support Level $12.55 $2.60
Resistance Level $13.09 $3.30
Average True Range (ATR) 0.57 0.06
MACD 0.23 0.03
Stochastic Oscillator 82.45 83.78

Price Performance

Historical Comparison
HLF
EVO

About HLF Herbalife Ltd.

Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: